CARDIFF ONCOLOGY, INC. Revenue Breakdown
No Revenue Breakdown for CRDF on this site yet.
- 2025-12-31: Others Not split by product in the filing$593.00K100.00%; Total revenue $593.00K.
- 2024-12-31: Others Not split by product in the filing$683.00K100.00%; Total revenue $683.00K.
- 2023-12-31: Total revenue $488.00K.
- 2022-12-31: Total revenue $386.00K.
Source checked: the stored Revenue Breakdown page for CRDF.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $593.00K 100.00% | $593.00K |
| 2024-12-31 | Not split by product in the filing $683.00K 100.00% | $683.00K |
| 2023-12-31 | $488.00K | |
| 2022-12-31 | $386.00K | |
| 2021-12-31 | $359.00K | |
| 2020-12-31 | $366.00K | |
| 2019-12-31 | $244.63K | |
| 2018-12-31 | $378.32K | |
| 2017-12-31 | Not split by product in the filing $505.40K 100.00% | $505.40K |
| 2016-12-31 | $381.07K | |
| 2015-12-31 | $312.81K | |
| 2014-12-31 | $280.18K | |
| 2013-12-31 | $259.25K | |
| 2012-12-31 | $450.40K | |
| 2011-12-31 | $257.70K |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $104.00K 100.00% | $104.00K |
| 2026-03-31 | Not split by product $41.00K 100.00% | $41.00K |
| 2025-12-31 | Not split by product $243.00K 100.00% | $243.00K |
| 2025-09-30 | Not split by product $120.00K 100.00% | $120.00K |
| 2025-06-30 | Not split by product $121.00K 100.00% | $121.00K |
| 2025-03-31 | Not split by product $109.00K 100.00% | $109.00K |
| 2024-12-31 | Not split by product $151.00K 100.00% | $151.00K |
| 2024-09-30 | Not split by product $165.00K 100.00% | $165.00K |
| 2024-06-30 | Not split by product $163.00K 100.00% | $163.00K |
| 2024-03-31 | Not split by product $205.00K 100.00% | $205.00K |
| 2023-12-31 | Not split by product $156.00K 100.00% | $156.00K |
| 2023-09-30 | Not split by product $141.00K 100.00% | $141.00K |
| 2023-06-30 | Not split by product $108.00K 100.00% | $108.00K |
| 2023-03-31 | Not split by product $83.00K 100.00% | $83.00K |
| 2022-12-31 | Not split by product $128.00K 100.00% | $128.00K |
| 2022-09-30 | Not split by product $93.00K 100.00% | $93.00K |
| 2022-06-30 | Not split by product $91.00K 100.00% | $91.00K |
| 2022-03-31 | Not split by product $74.00K 100.00% | $74.00K |
| 2021-12-31 | Not split by product $133.00K 100.00% | $133.00K |
| 2021-09-30 | Not split by product $86.00K 100.00% | $86.00K |
| 2021-06-30 | Not split by product $68.00K 100.00% | $68.00K |
| 2021-03-31 | Not split by product $72.00K 100.00% | $72.00K |
| 2020-12-31 | Not split by product $119.00K 100.00% | $119.00K |
| 2020-09-30 | Not split by product $136.00K 100.00% | $136.00K |
| 2020-06-30 | Not split by product $43.00K 100.00% | $43.00K |
| 2020-03-31 | Not split by product $68.00K 100.00% | $68.00K |
| 2019-12-31 | Not split by product $92.58K 100.00% | $92.58K |
| 2019-09-30 | Not split by product $51.69K 100.00% | $51.69K |
| 2019-06-30 | Not split by product $36.85K 100.00% | $36.85K |
| 2019-03-31 | Not split by product $62.02K 100.00% | $62.02K |
| 2018-12-31 | Not split by product $78.02K 100.00% | $78.02K |
| 2018-09-30 | Not split by product $88.36K 100.00% | $88.36K |
| 2018-06-30 | Not split by product $111.81K 100.00% | $111.81K |
| 2018-03-31 | Not split by product $100.14K 100.00% | $100.14K |
| 2017-12-31 | Not split by product $185.00K 100.00% | $185.00K |
| 2017-09-30 | Not split by product $123.33K 100.00% | $123.33K |
| 2017-06-30 | Not split by product $102.01K 100.00% | $102.01K |
| 2017-03-31 | Not split by product $95.04K 100.00% | $95.04K |
| 2016-12-31 | Not split by product $68.00K 100.00% | $68.00K |
| 2016-09-30 | Not split by product $89.00K 100.00% | $89.00K |
| 2016-06-30 | Not split by product $104.00K 100.00% | $104.00K |
| 2016-03-31 | Not split by product $120.00K 100.00% | $120.00K |
| 2015-12-31 | Not split by product $79.00K 100.00% | $79.00K |
| 2015-09-30 | Not split by product $58.00K 100.00% | $58.00K |
| 2015-06-30 | Not split by product $49.00K 100.00% | $49.00K |
| 2015-03-31 | Not split by product $127.00K 100.00% | $127.00K |
| 2014-12-31 | Not split by product $56.00K 100.00% | $56.00K |
| 2014-09-30 | Not split by product $57.00K 100.00% | $57.00K |
| 2014-06-30 | Not split by product $56.00K 100.00% | $56.00K |
| 2014-03-31 | Not split by product $111.00K 100.00% | $111.00K |
| 2013-12-31 | Not split by product $47.00K 100.00% | $47.00K |
| 2013-09-30 | Not split by product $44.00K 100.00% | $44.00K |
| 2013-06-30 | Not split by product $49.00K 100.00% | $49.00K |
| 2013-03-31 | Not split by product $119.00K 100.00% | $119.00K |
| 2012-12-31 | Not split by product $163.00K 100.00% | $163.00K |
| 2012-09-30 | Not split by product $212.00K 100.00% | $212.00K |
| 2012-06-30 | Not split by product $42.00K 100.00% | $42.00K |
| 2012-03-31 | Not split by product $34.00K 100.00% | $34.00K |
| 2011-12-31 | Not split by product $33.75K 100.00% | $33.75K |
| 2011-09-30 | Not split by product $55.00K 100.00% | $55.00K |
| 2011-06-30 | Not split by product $79.86K 100.00% | $79.86K |
| 2011-03-31 | Not split by product $89.08K 100.00% | $89.08K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |